Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Faes Farma SA (Faes Farma) develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, over-the-counter medications and skin-care treatment products. Faes Farma also provides the raw-materials for pharmaceutical companies. Its product portfolio consists of active pharmaceutical ingredients and finished drugs. The company’s product portfolio includes Actimag, Bronquidiazina CR, Bilaxten, Colme, Claversal, Dolotren, Dynamogen, Dolotren gel, Ferroprotina, Hidroferol, Lipofen, Potenciator, Positon and others. The company operates in Spain and Portugal. It also exports its products to several countries in Europe, Asia, Latin America, Africa and the Middle East. Faes Farma is headquartered in Madrid, Spain.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 - About the Company 5
Faes Farma SA - Key Facts 5
Faes Farma SA - Key Employees 6
Faes Farma SA - Major Products and Services 7
Faes Farma SA - Pharmaceutical Pipeline Products Data 9
Faes Farma SA, Pipeline Products by Therapy Area 9
Faes Farma SA, Pipeline Products by Development Phase 10
Faes Farma SA - History 11
Faes Farma SA - Company Statement 14
Faes Farma SA - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 16
Faes Farma SA - Business Description 16
Faes Farma SA - Corporate Strategy 17
Faes Farma SA - SWOT Analysis 18
SWOT Analysis - Overview 18
Faes Farma SA - Strengths 18
Faes Farma SA - Weaknesses 19
Faes Farma SA - Opportunities 20
Faes Farma SA - Threats 21
Faes Farma SA - Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios - Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
Faes Farma SA, Recent Deals Summary 30
Section 5 – Appendix 31
Methodology 31
Ratio Definitions 31
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
Faes Farma SA, Key Facts 5
Faes Farma SA, Key Employees 6
Faes Farma SA, Major Products and Services 7
Faes Farma SA, Number of Pipeline Products by Therapy Area 9
Faes Farma SA, Number of Pipeline Products by Development Stage 10
Faes Farma SA, History 11
Faes Farma SA, Subsidiaries 15
Faes Farma SA, Key Competitors 22
Faes Farma SA, Ratios based on current share price 23
Faes Farma SA, Annual Ratios 24
Faes Farma SA (Cont...1), Annual Ratios 25
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
Faes Farma SA, Recent Deals Summary 30
Currency Codes 31
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 32
Cost Ratios 33
Liquidity Ratios 33
Leverage Ratios 33
Efficiency Ratios 34
List of Figures
Faes Farma SA, Pipeline Products by Therapy Area 9
Faes Farma SA, Pipeline Products by Development Phase 10
Faes Farma SA, Performance Chart (2011 - 2015) 26
Faes Farma SA, Ratio Charts 27
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 29